CARE vs RF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CARE

63.5
AI Score
VS
CARE Wins

RF

56.0
AI Score

Investment Advisor Scores

CARE

Oct 22, 2026
64score
Recommendation
STRONG BUY

RF

Oct 22, 2026
56score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE RF Winner
Forward P/E 13.6612 9.4429 RF
PEG Ratio 0 1.4531 Tie
Revenue Growth 68.3% 5.2% CARE
Earnings Growth 253.9% 16.4% CARE
Tradestie Score 63.5/100 56.0/100 CARE
Profit Margin 44.9% 31.3% CARE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation STRONG BUY BUY CARE

Relative Price Performance (Last 90 Days)

CARE 1M: +2.6% · 3M: -9.7% RF 1M: +3.7% · 3M: -8.0%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.2 · Price: $30.70

RF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.6 · Price: $28.40

Fundamentals Snapshot

Metric CARE RF
Market Cap — —
Forward P/E 11.8 10.0
Trailing P/E 5.2 11.4
Revenue (TTM) — —
Revenue Growth 0.7% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.4%
EPS 5.83 2.47
Dividend Yield 0.00% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.